NEXPOINT ASSET MANAGEMENT, L.P. - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 190 filers reported holding HERON THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
NEXPOINT ASSET MANAGEMENT, L.P. ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$514,105
-11.2%
499,1310.0%0.07%
-16.7%
Q2 2023$578,992
-23.2%
499,1310.0%0.08%
+2.4%
Q1 2023$753,688
-39.6%
499,1310.0%0.08%
-15.5%
Q4 2022$1,247,828
-40.7%
499,1310.0%0.10%
-31.2%
Q3 2022$2,106,000
+51.2%
499,1310.0%0.14%
+13.7%
Q2 2022$1,393,000
-51.2%
499,1310.0%0.12%
-66.3%
Q1 2022$2,855,000
-37.3%
499,1310.0%0.37%
-42.7%
Q4 2021$4,557,000
-14.6%
499,1310.0%0.64%
-30.1%
Q3 2021$5,336,000
-31.1%
499,1310.0%0.92%
-45.7%
Q2 2021$7,747,000
-21.6%
499,131
-18.1%
1.69%
-34.5%
Q1 2021$9,880,000
-35.3%
609,531
-15.5%
2.58%
-48.6%
Q4 2020$15,261,000
+42.8%
721,0640.0%5.02%
+107.6%
Q3 2020$10,686,000
+0.7%
721,0640.0%2.42%
+1.2%
Q2 2020$10,607,000
+16.2%
721,064
-7.3%
2.39%
+38.6%
Q1 2020$9,129,000
-67.6%
777,599
-35.1%
1.72%
-19.3%
Q4 2019$28,144,000
-2.6%
1,197,599
-23.3%
2.14%
+18.5%
Q3 2019$28,896,0001,561,9811.80%
Other shareholders
HERON THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders